{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:20:37Z","timestamp":1792196437165,"version":"4.4.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11537-z","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:43:45Z","timestamp":1771505025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long COVID-associated neurological symptoms and brain fog: Understanding the mechanism of neuroinflammation, BBB disruption, diagnostics, and therapeutics"],"prefix":"10.1007","volume":"53","author":[{"given":"Chiranjib","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manojit","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srijan","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"11537_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","volume":"54","author":"D Castanares-Zapatero","year":"2022","unstructured":"Castanares-Zapatero D et al (2022) Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 54(1):1473\u20131487","journal-title":"Ann Med"},{"issue":"3","key":"11537_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE et al (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133\u2013146","journal-title":"Nat Rev Microbiol"},{"key":"11537_CR3","doi-asserted-by":"publisher","first-page":"111930","DOI":"10.1016\/j.intimp.2024.111930","volume":"132","author":"M Bhattacharya","year":"2024","unstructured":"Bhattacharya M et al (2024) Current landscape of long COVID clinical trials. Int Immunopharmacol 132:111930","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"11537_CR4","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jiph.2024.02.018","volume":"17","author":"C Chakraborty","year":"2024","unstructured":"Chakraborty C et al (2024) Blueprint of differentially expressed genes reveals the dynamic gene expression landscape and the gender biases in long COVID. J Infect Public Health 17(5):748\u2013766","journal-title":"J Infect Public Health"},{"key":"11537_CR5","doi-asserted-by":"publisher","first-page":"n1648","DOI":"10.1136\/bmj.n1648","volume":"374","author":"H Crook","year":"2021","unstructured":"Crook H et al (2021) Long covid-mechanisms, risk factors, and management. BMJ 374:n1648","journal-title":"BMJ"},{"key":"11537_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.omtn.2023.08.016","volume":"33","author":"C Chakraborty","year":"2023","unstructured":"Chakraborty C, Bhattacharya M (2023) The current landscape of long COVID clinical trials: nih\u2019s RECOVER to Stanford medicine\u2019s STOP-PASC initiative. Mol Ther Nucleic Acids 33:887\u2013889","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"11537_CR7","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian A et al (2022) Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 28(8):1706\u20131714","journal-title":"Nat Med"},{"issue":"4","key":"11537_CR8","doi-asserted-by":"publisher","first-page":"e2315","DOI":"10.1002\/rmv.2315","volume":"32","author":"SJ Yong","year":"2022","unstructured":"Yong SJ, Liu S (2022) Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol 32(4):e2315","journal-title":"Rev Med Virol"},{"key":"11537_CR9","doi-asserted-by":"publisher","first-page":"113426","DOI":"10.1016\/j.socscimed.2020.113426","volume":"268","author":"F Callard","year":"2021","unstructured":"Callard F, Perego E (2021) How and why patients made long Covid. Soc Sci Med 268:113426","journal-title":"Soc Sci Med"},{"issue":"1","key":"11537_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s15010-021-01696-5","volume":"50","author":"C Fernandez-de-Las-Penas","year":"2022","unstructured":"Fernandez-de-Las-Penas C, Long COVID (2022) Current definition. Infection 50(1):285\u2013286","journal-title":"Infection"},{"key":"11537_CR11","doi-asserted-by":"publisher","unstructured":"Mina Y et al (2023) Deep phenotyping of neurologic postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000200097","DOI":"10.1212\/NXI.0000000000200097"},{"issue":"2","key":"11537_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.amjmed.2023.06.010","volume":"138","author":"MC Seeley","year":"2025","unstructured":"Seeley MC et al (2025) High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long COVID: implications for management and health care planning. Am J Med 138(2):354\u2013361e1","journal-title":"Am J Med"},{"key":"11537_CR13","doi-asserted-by":"publisher","unstructured":"Malkova A et al (2021) Post COVID-19 syndrome in patients with Asymptomatic\/Mild form. Pathogens. https:\/\/doi.org\/10.3390\/pathogens10111408","DOI":"10.3390\/pathogens10111408"},{"issue":"4","key":"11537_CR14","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB et al (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22(4):e102\u2013e107","journal-title":"Lancet Infect Dis"},{"key":"11537_CR15","unstructured":"CDC, National center for immunization and respiratory diseases (NCIRD) DoVD. long COVID or post-COVID conditions (2022) https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effects\/. 2022"},{"key":"11537_CR16","unstructured":"National Institute for Health and Care Excellence (NICE) S, o.I., (RCGP) GP., COVID-19 rapid guideline: Managing the long-term effects of COVID-19 (2022) https:\/\/www.nice.org.uk\/guidance\/ng188. 2022"},{"key":"11537_CR17","unstructured":"TAAoPMaR. AR (2022) Post-acute sequelae of SARS-CoV-2 infection (PASC) estimates and insights. dashboard https:\/\/pascdashboard.aapmr.org\/. 2022"},{"key":"11537_CR18","doi-asserted-by":"crossref","unstructured":"Bull-Otterson L (2022) Post\u2013COVID conditions among adult COVID-19 survivors aged 18\u201364 and \u2265\u200965 years\u2014United States, March 2020\u2013November 2021. MMWR. Morbidity and Mortality Weekly Report, p 71","DOI":"10.15585\/mmwr.mm7121e1"},{"key":"11537_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","volume":"101","author":"F Ceban","year":"2022","unstructured":"Ceban F et al (2022) Fatigue and cognitive impairment in Post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav Immun 101:93\u2013135","journal-title":"Brain Behav Immun"},{"issue":"7","key":"11537_CR20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","volume":"28","author":"Z Al-Aly","year":"2022","unstructured":"Al-Aly Z, Bowe B, Xie Y (2022) Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 28(7):1461\u20131467","journal-title":"Nat Med"},{"issue":"9","key":"11537_CR21","doi-asserted-by":"publisher","first-page":"ofac464","DOI":"10.1093\/ofid\/ofac464","volume":"9","author":"D Ayoubkhani","year":"2022","unstructured":"Ayoubkhani D et al (2022) Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: Community-Based, matched cohort study. Open Forum Infect Dis 9(9):ofac464","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"11537_CR22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen C et al (2022) Global prevalence of Post-Coronavirus disease 2019 (COVID-19) condition or long COVID: A Meta-Analysis and systematic review. J Infect Dis 226(9):1593\u20131607","journal-title":"J Infect Dis"},{"key":"11537_CR23","doi-asserted-by":"publisher","unstructured":"Han Q et al (2022) Long-Term sequelae of COVID-19: A systematic review and Meta-Analysis of One-Year Follow-Up studies on Post-COVID symptoms. Pathogens. https:\/\/doi.org\/10.3390\/pathogens11020269","DOI":"10.3390\/pathogens11020269"},{"issue":"2","key":"11537_CR24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.joim.2025.01.001","volume":"23","author":"MS Tsang","year":"2025","unstructured":"Tsang MS et al (2025) Chinese herbal medicine for dyspnea and persistent symptoms of long COVID: A systematic review and meta-analysis of randomized controlled trials. J Integr Med 23(2):126\u2013137","journal-title":"J Integr Med"},{"issue":"6","key":"11537_CR25","doi-asserted-by":"publisher","first-page":"e70429","DOI":"10.1002\/jmv.70429","volume":"97","author":"M Rahmati","year":"2025","unstructured":"Rahmati M et al (2025) Long-Term sequelae of COVID-19: A systematic review and Meta-Analysis of symptoms 3 years Post-SARS-CoV-2 infection. J Med Virol 97(6):e70429","journal-title":"J Med Virol"},{"key":"11537_CR26","unstructured":"Health. F (2022) Patients Diagnosed with Post-COVID Conditions: An Analysis of Private Healthcare Claims Using the Official ICD-10 Diagnostic CodeFAIR Health, 2022"},{"issue":"4","key":"11537_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jnnp-2022-329683","volume":"94","author":"L McWhirter","year":"2023","unstructured":"McWhirter L et al (2023) What is brain fog? J Neurol Neurosurg Psychiatry 94(4):321\u2013325","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11537_CR28","doi-asserted-by":"publisher","unstructured":"Jennings G et al (2022) Comprehensive clinical characterisation of brain fog in adults reporting long COVID symptoms. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11123440","DOI":"10.3390\/jcm11123440"},{"issue":"3","key":"11537_CR29","first-page":"274","volume":"62","author":"AM Kirmizibekmez","year":"2025","unstructured":"Kirmizibekmez AM et al (2025) Is neurodegeneration accelerated? Investigating COVID-19\u2019s impact on dementia via functional connectivity. Noro Psikiyatr Ars 62(3):274\u2013278","journal-title":"Noro Psikiyatr Ars"},{"key":"11537_CR30","doi-asserted-by":"publisher","first-page":"e081349","DOI":"10.1136\/bmj-2024-081349","volume":"390","author":"E Aretouli","year":"2025","unstructured":"Aretouli E et al (2025) Cognitive and mental health outcomes in long Covid. BMJ 390:e081349","journal-title":"BMJ"},{"issue":"6","key":"11537_CR31","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10286-013-0212-z","volume":"23","author":"AJ Ross","year":"2013","unstructured":"Ross AJ et al (2013) What is brain fog? An evaluation of the symptom in postural tachycardia syndrome. Clin Auton Res 23(6):305\u2013311","journal-title":"Clin Auton Res"},{"issue":"7508","key":"11537_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/511125a","volume":"511","author":"Bfog Editorial","year":"2014","unstructured":"Editorial Bfog (2014) Nature 511(7508):125","journal-title":"Nature"},{"issue":"5","key":"11537_CR33","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/apt.12867","volume":"40","author":"IT Lichtwark","year":"2014","unstructured":"Lichtwark IT et al (2014) Editorial: \u2018brain fog\u2019 and coeliac disease - evidence for its existence: authors\u2019 reply. Aliment Pharmacol Ther 40(5):566","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"11537_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1439-0272.1989.tb02462.x","volume":"21","author":"S Moslein-Rossmeissl","year":"1989","unstructured":"Moslein-Rossmeissl S, Taubert HD (1989) Male subfertility and the outcome of intrauterine insemination. Andrologia 21(6):519\u2013522","journal-title":"Andrologia"},{"issue":"1\u20133","key":"11537_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12026-015-8716-3","volume":"63","author":"M Mackay","year":"2015","unstructured":"Mackay M (2015) Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus. Immunol Res 63(1\u20133):26\u201337","journal-title":"Immunol Res"},{"issue":"14","key":"11537_CR36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1080\/15384101.2017.1334022","volume":"16","author":"A Kovalchuk","year":"2017","unstructured":"Kovalchuk A, Kolb B (2017) Chemo brain: from discerning mechanisms to lifting the brain fog-An aging connection. Cell Cycle 16(14):1345\u20131349","journal-title":"Cell Cycle"},{"issue":"5","key":"11537_CR37","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/apt.12852","volume":"40","author":"B Lebwohl","year":"2014","unstructured":"Lebwohl B, Ludvigsson JF (2014) Editorial: \u2018brain fog\u2019 and coeliac disease - evidence for its existence. Aliment Pharmacol Ther 40(5):565","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"11537_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/jgh.13706","volume":"32","author":"GW Yelland","year":"2017","unstructured":"Yelland GW (2017) Gluten-induced cognitive impairment (brain fog) in coeliac disease. J Gastroenterol Hepatol 32(Suppl 1):90\u201393","journal-title":"J Gastroenterol Hepatol"},{"key":"11537_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fnins.2015.00225","volume":"9","author":"TC Theoharides","year":"2015","unstructured":"Theoharides TC et al (2015) Brain fog, inflammation and obesity: key aspects of neuropsychiatric disorders improved by Luteolin. Front Neurosci 9:225","journal-title":"Front Neurosci"},{"issue":"5","key":"11537_CR40","doi-asserted-by":"publisher","first-page":"52001","DOI":"10.1289\/EHP4869","volume":"127","author":"S Schmidt","year":"2019","unstructured":"Schmidt S (2019) Brain fog: does air pollution make Us less productive? Environ health perspect 127(5):52001","journal-title":"Environ health perspect"},{"key":"11537_CR41","first-page":"101","volume":"11","author":"ND Mukhtarova","year":"1987","unstructured":"Mukhtarova ND (1987) Changes in the nervous system of patients with allergies developing in a furniture manufacturing setting. Vrach Delo 11:101\u2013104","journal-title":"Vrach Delo"},{"key":"11537_CR42","doi-asserted-by":"crossref","unstructured":"Dabrowska E, Galinska-Skok B, Waszkiewicz N (2021) Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19. Life (Basel), 11(10)","DOI":"10.3390\/life11101056"},{"issue":"5","key":"11537_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3892\/etm.2022.11290","volume":"23","author":"V Efstathiou","year":"2022","unstructured":"Efstathiou V et al (2022) Long COVID and neuropsychiatric manifestations (Review). Exp Ther Med 23(5):363","journal-title":"Exp Ther Med"},{"issue":"3","key":"11537_CR44","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/neurolint15030052","volume":"15","author":"AB Reiss","year":"2023","unstructured":"Reiss AB, Long COVID et al (2023) The Brain, Nerves, and cognitive function. Neurol Int 15(3):821\u2013841","journal-title":"Neurol Int"},{"issue":"8","key":"11537_CR45","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00406-023-01721-8","volume":"274","author":"RSK Shil","year":"2024","unstructured":"Shil RSK et al (2024) A clinical approach to the investigation and management of long COVID associated neuropathic pain. Eur Arch Psychiatry Clin Neurosci 274(8):1787\u20131795","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"11537_CR46","doi-asserted-by":"publisher","unstructured":"Marchesi N et al (2025) Exploring the potential of dietary supplements to alleviate pain due to long COVID. Nutrients. https:\/\/doi.org\/10.3390\/nu17071287","DOI":"10.3390\/nu17071287"},{"key":"11537_CR47","first-page":"102068","volume":"43","author":"WT Al Masoodi","year":"2025","unstructured":"Al Masoodi WT et al (2025) Role of Galanin system and insulin resistance parameters as predictive tools for diagnosis of Long-COVID patients. Biochem Biophys Rep 43:102068","journal-title":"Biochem Biophys Rep"},{"key":"11537_CR48","doi-asserted-by":"crossref","unstructured":"Hein ZM et al (2025) Immunomodulatory mechanisms underlying neurological manifestations in long COVID: implications for Immune-Mediated neurodegeneration. Int J Mol Sci, 26(13):6214","DOI":"10.3390\/ijms26136214"},{"issue":"6","key":"11537_CR49","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.drudis.2021.02.009","volume":"26","author":"ME Collier","year":"2021","unstructured":"Collier ME et al (2021) Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition? Drug Discov Today 26(6):1473\u20131481","journal-title":"Drug Discov Today"},{"issue":"5","key":"11537_CR50","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/alz.12644","volume":"18","author":"L Crivelli","year":"2022","unstructured":"Crivelli L et al (2022) Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimers Dement 18(5):1047\u20131066","journal-title":"Alzheimers Dement"},{"issue":"8","key":"11537_CR51","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s11064-023-03912-0","volume":"48","author":"I Kazama","year":"2023","unstructured":"Kazama I (2023) Brain leukocytes as the potential therapeutic target for Post-COVID-19 brain fog. Neurochem Res 48(8):2345\u20132349","journal-title":"Neurochem Res"},{"key":"11537_CR52","doi-asserted-by":"publisher","unstructured":"Lou JJ et al (2021) Neuropathology of COVID-19 (neuro-COVID): clinicopathological update. Free Neuropathol, 2:2 https:\/\/doi.org\/10.17879\/freeneuropathology-2021-2993","DOI":"10.17879\/freeneuropathology-2021-2993"},{"issue":"9","key":"11537_CR53","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/brain\/awab148","volume":"144","author":"KT Thakur","year":"2021","unstructured":"Thakur KT et al (2021) COVID-19 neuropathology at Columbia university Irving medical Center\/New York presbyterian hospital. Brain 144(9):2696\u20132708","journal-title":"Brain"},{"key":"11537_CR54","doi-asserted-by":"publisher","first-page":"204062232210768","DOI":"10.1177\/20406223221076890","volume":"13","author":"MI Stefanou","year":"2022","unstructured":"Stefanou MI et al (2022) Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis 13:20406223221076890","journal-title":"Ther Adv Chronic Dis"},{"issue":"7941","key":"11537_CR55","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"SR Stein","year":"2022","unstructured":"Stein SR et al (2022) SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612(7941):758\u2013763","journal-title":"Nature"},{"issue":"3","key":"11537_CR56","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2023","unstructured":"Swank Z et al (2023) Persistent Circulating severe acute respiratory syndrome coronavirus 2 Spike is associated with Post-acute coronavirus disease 2019 sequelae. Clin Infect Dis 76(3):e487\u2013e490","journal-title":"Clin Infect Dis"},{"issue":"3","key":"11537_CR57","doi-asserted-by":"publisher","first-page":"e70019","DOI":"10.1002\/cph4.70019","volume":"15","author":"G Gupta","year":"2025","unstructured":"Gupta G et al (2025) Mechanistic insights into long covid: viral Persistence, immune Dysregulation, and Multi-Organ dysfunction. Compr Physiol 15(3):e70019","journal-title":"Compr Physiol"},{"issue":"4","key":"11537_CR58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1473-3099(23)00053-1","volume":"23","author":"A Iwasaki","year":"2023","unstructured":"Iwasaki A, Putrino D (2023) Why we need a deeper Understanding of the pathophysiology of long COVID. Lancet Infect Dis 23(4):393\u2013395","journal-title":"Lancet Infect Dis"},{"key":"11537_CR59","doi-asserted-by":"publisher","first-page":"100100","DOI":"10.1016\/j.jtauto.2021.100100","volume":"4","author":"G Wallukat","year":"2021","unstructured":"Wallukat G et al (2021) Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 4:100100","journal-title":"J Transl Autoimmun"},{"issue":"14","key":"11537_CR60","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.cell.2022.06.008","volume":"185","author":"A Fernandez-Castaneda","year":"2022","unstructured":"Fernandez-Castaneda A et al (2022) Mild respiratory COVID can cause multi-lineage neural cell and Myelin dysregulation. Cell 185(14):2452\u20132468e16","journal-title":"Cell"},{"issue":"4","key":"11537_CR61","first-page":"799","volume":"44","author":"SN Robinson","year":"1987","unstructured":"Robinson SN, Crane VS, Jones DG (1987) Pharmaceutical services in an extracorporeal shock wave lithotripsy center. Am J Hosp Pharm 44(4):799\u2013802","journal-title":"Am J Hosp Pharm"},{"key":"11537_CR62","doi-asserted-by":"publisher","first-page":"153951","DOI":"10.1016\/j.metabol.2019.153951","volume":"100S","author":"JP O\u2019Callaghan","year":"2019","unstructured":"O\u2019Callaghan JP, Miller DB (2019) Neuroinflammation disorders exacerbated by environmental stressors. Metabolism 100S:153951","journal-title":"Metabolism"},{"key":"11537_CR63","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbi.2022.02.018","volume":"102","author":"L Brusaferri","year":"2022","unstructured":"Brusaferri L et al (2022) The pandemic brain: neuroinflammation in non-infected individuals during the COVID-19 pandemic. Brain Behav Immun 102:89\u201397","journal-title":"Brain Behav Immun"},{"key":"11537_CR64","doi-asserted-by":"publisher","first-page":"877772","DOI":"10.3389\/fneur.2022.877772","volume":"13","author":"W Tate","year":"2022","unstructured":"Tate W et al (2022) Molecular mechanisms of neuroinflammation in ME\/CFS and long COVID to sustain disease and promote relapses. Front Neurol 13:877772","journal-title":"Front Neurol"},{"issue":"1","key":"11537_CR65","doi-asserted-by":"publisher","first-page":"iqac007","DOI":"10.1093\/oxfimm\/iqac007","volume":"3","author":"E Kavanagh","year":"2022","unstructured":"Kavanagh E (2022) Long Covid brain fog: a neuroinflammation phenomenon? Oxf Open Immunol 3(1):iqac007","journal-title":"Oxf Open Immunol"},{"issue":"2","key":"11537_CR66","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11481-021-09986-3","volume":"16","author":"AJM Chaves Filho","year":"2021","unstructured":"Chaves Filho AJM et al (2021) Repurposing of tetracyclines for COVID-19 neurological and neuropsychiatric manifestations: A valid option to control SARS-CoV-2-Associated neuroinflammation? J Neuroimmune Pharmacol 16(2):213\u2013218","journal-title":"J Neuroimmune Pharmacol"},{"issue":"10223","key":"11537_CR67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"issue":"5","key":"11537_CR68","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2213-2600(21)00125-9","volume":"9","author":"WJ Song","year":"2021","unstructured":"Song WJ et al (2021) Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med 9(5):533\u2013544","journal-title":"Lancet Respir Med"},{"issue":"2","key":"11537_CR69","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1523\/JNEUROSCI.22-02-00486.2002","volume":"22","author":"L Vallieres","year":"2002","unstructured":"Vallieres L et al (2002) Reduced hippocampal neurogenesis in adult Transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci 22(2):486\u2013492","journal-title":"J Neurosci"},{"issue":"2","key":"11537_CR70","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bbi.2011.09.012","volume":"26","author":"MD Wu","year":"2012","unstructured":"Wu MD et al (2012) Adult murine hippocampal neurogenesis is inhibited by sustained IL-1beta and not rescued by voluntary running. Brain Behav Immun 26(2):292\u2013300","journal-title":"Brain Behav Immun"},{"issue":"8006","key":"11537_CR71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/d41586-024-00828-9","volume":"628","author":"C Lopez Lloreda","year":"2024","unstructured":"Lopez Lloreda C (2024) COVID\u2019s toll on the brain: new clues emerge. Nature 628(8006):20","journal-title":"Nature"},{"key":"11537_CR72","doi-asserted-by":"publisher","unstructured":"Cardenas-Rodriguez N et al (2024) Possible role of cannabis in the management of neuroinflammation in patients with Post-COVID condition. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25073805","DOI":"10.3390\/ijms25073805"},{"issue":"11","key":"11537_CR73","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1016\/j.mayocp.2021.07.004","volume":"96","author":"L Bateman","year":"2021","unstructured":"Bateman L et al (2021) Myalgic Encephalomyelitis\/Chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc 96(11):2861\u20132878","journal-title":"Mayo Clin Proc"},{"key":"11537_CR74","doi-asserted-by":"publisher","first-page":"701419","DOI":"10.3389\/fneur.2021.701419","volume":"12","author":"A Mackay","year":"2021","unstructured":"Mackay A (2021) A paradigm for Post-Covid-19 fatigue syndrome analogous to ME\/CFS. Front Neurol 12:701419","journal-title":"Front Neurol"},{"key":"11537_CR75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0074-7742(07)82012-5","volume":"82","author":"J Rogers","year":"2007","unstructured":"Rogers J et al (2007) Neuroinflammation in alzheimer\u2019s disease and parkinson\u2019s disease: are microglia pathogenic in either disorder? Int Rev Neurobiol 82:235\u2013246","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"11537_CR76","first-page":"100461","volume":"7","author":"E Pettemeridou","year":"2025","unstructured":"Pettemeridou E et al (2025) Cognitive and psychological symptoms in Post-COVID-19 condition: A systematic review of structural and functional Neuroimaging, Neurophysiology, and intervention studies. Arch Rehabil Res Clin Transl 7(3):100461","journal-title":"Arch Rehabil Res Clin Transl"},{"key":"11537_CR77","doi-asserted-by":"crossref","unstructured":"Martins D et al (2025) Understanding Neuroinflammation in Post-COVID-19 Syndrome: Biological Mechanisms, Diagnostic Biomarkers, and Therapeutic Prospects. Translational psychiatry","DOI":"10.20944\/preprints202506.1469.v1"},{"issue":"1","key":"11537_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ et al (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37(1):13\u201325","journal-title":"Neurobiol Dis"},{"issue":"1","key":"11537_CR79","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"R Daneman","year":"2015","unstructured":"Daneman R, Prat A (2015) The blood-brain barrier. Cold Spring Harb Perspect Biol 7(1):a020412","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"11537_CR80","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijpharm.2019.01.056","volume":"559","author":"G Sharma","year":"2019","unstructured":"Sharma G et al (2019) Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int J Pharm 559:360\u2013372","journal-title":"Int J Pharm"},{"key":"11537_CR81","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.omtn.2019.12.024","volume":"19","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty C et al (2020) MicroRNAs: possible regulatory molecular switch controlling the BBB microenvironment. Mol Ther Nucleic Acids 19:933\u2013936","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"11537_CR82","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11060-008-9759-2","volume":"93","author":"C Chakraborty","year":"2009","unstructured":"Chakraborty C et al (2009) Future prospects of nanoparticles on brain targeted drug delivery. J Neurooncol 93(2):285\u2013286","journal-title":"J Neurooncol"},{"issue":"1","key":"11537_CR83","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","volume":"16","author":"C Greene","year":"2019","unstructured":"Greene C, Hanley N, Campbell M (2019) Claudin-5: gatekeeper of neurological function. Fluids Barriers CNS 16(1):3","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"11537_CR84","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1186\/s12879-025-11333-3","volume":"25","author":"P Yin","year":"2025","unstructured":"Yin P et al (2025) Clinical, thyroid metabolic, and inflammatory features in pediatric patients with post-acute COVID-19 neuropsychiatric symptoms. BMC Infect Dis 25(1):963","journal-title":"BMC Infect Dis"},{"key":"11537_CR85","doi-asserted-by":"crossref","unstructured":"Matos A et al (2025) Comparative analysis of cytokines and neurological biomarkers in Post-COVID-19 encephalitis and encephalopathy (P1-10.008). Neurology. Lippincott Williams & Wilkins Hagerstown, MD. 104 (7_Supplement_1) 4730","DOI":"10.1212\/WNL.0000000000211874"},{"issue":"7868","key":"11537_CR86","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","volume":"595","author":"AC Yang","year":"2021","unstructured":"Yang AC et al (2021) Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 595(7868):565\u2013571","journal-title":"Nature"},{"issue":"11","key":"11537_CR87","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/s41593-021-00926-1","volume":"24","author":"J Wenzel","year":"2021","unstructured":"Wenzel J et al (2021) The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci 24(11):1522\u20131533","journal-title":"Nat Neurosci"},{"issue":"3","key":"11537_CR88","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","volume":"27","author":"C Greene","year":"2024","unstructured":"Greene C et al (2024) Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci 27(3):421\u2013432","journal-title":"Nat Neurosci"},{"key":"11537_CR89","doi-asserted-by":"publisher","first-page":"1070379","DOI":"10.3389\/fimmu.2022.1070379","volume":"13","author":"V Bonetto","year":"2022","unstructured":"Bonetto V et al (2022) Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol 13:1070379","journal-title":"Front Immunol"},{"issue":"7907","key":"11537_CR90","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","volume":"604","author":"G Douaud","year":"2022","unstructured":"Douaud G et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature 604(7907):697\u2013707","journal-title":"Nature"},{"key":"11537_CR91","doi-asserted-by":"publisher","unstructured":"Frosolini A et al (2022) Magnetic resonance imaging confirmed olfactory bulb reduction in long COVID-19: literature review and case series. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci12040430","DOI":"10.3390\/brainsci12040430"},{"key":"11537_CR92","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.bbi.2025.07.024","volume":"129","author":"LH Rubin","year":"2025","unstructured":"Rubin LH et al (2025) Blood-Brain barrier disruption in long COVID and cognitive correlates: A cross-sectional MRI study. Brain Behav Immun 129:989\u2013999","journal-title":"Brain Behav Immun"},{"issue":"3","key":"11537_CR93","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/vaccines11030682","volume":"11","author":"C Chakraborty","year":"2023","unstructured":"Chakraborty C, Bhattacharya M, Dhama K (2023) SARS-CoV-2 vaccines, vaccine development technologies, and significant efforts in vaccine development during the pandemic: the lessons learned might help to fight against the next pandemic. Vaccines 11(3):682","journal-title":"Vaccines"},{"key":"11537_CR94","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.coviro.2021.08.010","volume":"50","author":"J Zhang","year":"2021","unstructured":"Zhang J et al (2021) Structure of SARS-CoV-2 Spike protein. Curr Opin Virol 50:173\u2013182","journal-title":"Curr Opin Virol"},{"key":"11537_CR95","doi-asserted-by":"publisher","unstructured":"Bhattacharya M et al (2023) Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants. Drug Resist Updates. https:\/\/doi.org\/10.1016\/j.drup.2023.101008","DOI":"10.1016\/j.drup.2023.101008"},{"key":"11537_CR96","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ijbiomac.2022.07.254","volume":"219","author":"C Chakraborty","year":"2022","unstructured":"Chakraborty C et al (2022) Omicron (B. 1.1. 529)-A new heavily mutated variant: mapped location and probable properties of its mutations with an emphasis on S-glycoprotein. Int J Biol Macromol 219:980\u2013997","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"11537_CR97","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11357-022-00532-4","volume":"44","author":"M Bhattacharya","year":"2022","unstructured":"Bhattacharya M et al (2022) Omicron variant (B. 1.1. 529) of SARS-CoV-2: Understanding mutations in the genome, S-glycoprotein, and antibody-binding regions. GeroScience 44(2):619\u2013637","journal-title":"GeroScience"},{"issue":"3","key":"11537_CR98","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciac722","volume":"76","author":"Z Swank","year":"2023","unstructured":"Swank Z et al (2023) Persistent Circulating severe acute respiratory syndrome coronavirus 2 Spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis 76(3):e487\u2013e490","journal-title":"Clin Infect Dis"},{"issue":"5","key":"11537_CR99","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/cells12050688","volume":"12","author":"TC Theoharides","year":"2023","unstructured":"Theoharides TC, Kempuraj D (2023) Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID. Cells 12(5):688","journal-title":"Cells"},{"issue":"11","key":"11537_CR100","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1007\/s12035-023-03493-7","volume":"60","author":"I Tsilioni","year":"2023","unstructured":"Tsilioni I, Theoharides TC (2023) Recombinant SARS-CoV-2 Spike protein and its receptor binding domain stimulate release of different pro-inflammatory mediators via activation of distinct receptors on human microglia cells. Mol Neurobiol 60(11):6704\u20136714","journal-title":"Mol Neurobiol"},{"issue":"4","key":"11537_CR101","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/10738584231194927","volume":"30","author":"D Kempuraj","year":"2024","unstructured":"Kempuraj D et al (2024) COVID-19 and long COVID: disruption of the neurovascular unit, blood-brain barrier, and tight junctions. Neuroscientist 30(4):421\u2013439","journal-title":"Neuroscientist"},{"key":"11537_CR102","doi-asserted-by":"publisher","first-page":"1080043","DOI":"10.3389\/fimmu.2023.1080043","volume":"14","author":"G Ancona","year":"2023","unstructured":"Ancona G et al (2023) Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID. Front Immunol 14:1080043","journal-title":"Front Immunol"},{"issue":"5","key":"11537_CR103","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/cells12050816","volume":"12","author":"A Leng","year":"2023","unstructured":"Leng A et al (2023) Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells 12(5):816","journal-title":"Cells"},{"key":"11537_CR104","doi-asserted-by":"publisher","first-page":"1232480","DOI":"10.3389\/fnins.2023.1232480","volume":"17","author":"AM Plummer","year":"2023","unstructured":"Plummer AM et al (2023) Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms. Front Neurosci 17:1232480","journal-title":"Front Neurosci"},{"issue":"25","key":"11537_CR105","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3748\/wjg.v28.i25.2802","volume":"28","author":"C Chakraborty","year":"2022","unstructured":"Chakraborty C et al (2022) Altered gut microbiota patterns in COVID-19: markers for inflammation and disease severity. World J Gastroenterol 28(25):2802","journal-title":"World J Gastroenterol"},{"issue":"5","key":"11537_CR106","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41575-022-00698-4","volume":"20","author":"F Zhang","year":"2023","unstructured":"Zhang F et al (2023) Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat Reviews Gastroenterol Hepatol 20(5):323\u2013337","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"11537_CR107","doi-asserted-by":"publisher","first-page":"635471","DOI":"10.3389\/fimmu.2021.635471","volume":"12","author":"GLV de Oliveira","year":"2021","unstructured":"de Oliveira GLV et al (2021) Microbiota modulation of the gut-lung axis in COVID-19. Front Immunol 12:635471","journal-title":"Front Immunol"},{"issue":"1","key":"11537_CR108","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10020-024-00986-6","volume":"31","author":"NT Iqbal","year":"2025","unstructured":"Iqbal NT et al (2025) Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis. Mol Med 31(1):22","journal-title":"Mol Med"},{"issue":"1186","key":"11537_CR109","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/postmj\/qgae030","volume":"100","author":"N Kalam","year":"2024","unstructured":"Kalam N, Balasubramaniam V (2024) Crosstalk between COVID-19 and the gut-brain axis: a gut feeling. Postgrad Med J 100(1186):539\u2013554","journal-title":"Postgrad Med J"},{"issue":"4","key":"11537_CR110","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41380-023-02387-3","volume":"29","author":"D Hayek","year":"2024","unstructured":"Hayek D et al (2024) Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition. Mol Psychiatry 29(4):992\u20131004","journal-title":"Mol Psychiatry"},{"issue":"1","key":"11537_CR111","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L (2020) A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17(1):69","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"11537_CR112","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jim-2021-002051","volume":"70","author":"P Glynne","year":"2022","unstructured":"Glynne P et al (2022) Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med 70(1):61\u201367","journal-title":"J Investig Med"},{"issue":"36","key":"11537_CR113","doi-asserted-by":"publisher","first-page":"e2213524119","DOI":"10.1073\/pnas.2213524119","volume":"119","author":"L Shaffer","year":"2022","unstructured":"Shaffer L (2022) Lots of long COVID treatment leads, but few are proven. Proc Natl Acad Sci 119(36):e2213524119","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"11537_CR114","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3390\/ph3061949","volume":"3","author":"MA Ajmone-Cat","year":"2010","unstructured":"Ajmone-Cat MA et al (2010) Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions. Pharmaceuticals 3(6):1949\u20131965","journal-title":"Pharmaceuticals"},{"issue":"5","key":"11537_CR115","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3109\/08923973.2012.666249","volume":"34","author":"I Kazama","year":"2012","unstructured":"Kazama I, Maruyama Y, Murata Y (2012) Suppressive effects of nonsteroidal anti-inflammatory drugs diclofenac sodium, salicylate and indomethacin on delayed rectifier K+-channel currents in murine thymocytes. Immunopharmacol Immunotoxicol 34(5):874\u2013878","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"4","key":"11537_CR116","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.pharep.2014.03.002","volume":"66","author":"I Kazama","year":"2014","unstructured":"Kazama I, Baba A, Maruyama Y (2014) HMG-CoA reductase inhibitors pravastatin, Lovastatin and Simvastatin suppress delayed rectifier K(+)-channel currents in murine thymocytes. Pharmacol Rep 66(4):712\u2013717","journal-title":"Pharmacol Rep"},{"issue":"2","key":"11537_CR117","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/neurolint15020045","volume":"15","author":"A Fesharaki Zadeh","year":"2023","unstructured":"Fesharaki Zadeh A, Arnsten AFT, Wang M (2023) Scientific rationale for the treatment of cognitive deficits from long COVID. Neurol Int 15(2):725\u2013742","journal-title":"Neurol Int"},{"key":"11537_CR118","unstructured":"Backman I (2022) Potential New Treatment for Brain Fog in Long COVID Patients. https:\/\/medicine.yale.edu\/news-article\/potential-new-treatment-for-brain-fog-in-long-covid-patients\/, acessed on 17\/04\/2024"},{"issue":"8","key":"11537_CR119","doi-asserted-by":"publisher","first-page":"e202200391","DOI":"10.1002\/jbio.202200391","volume":"16","author":"R Bowen","year":"2023","unstructured":"Bowen R, Arany PR (2023) Use of either transcranial or whole-body photobiomodulation treatments improves COVID-19 brain fog. J Biophotonics 16(8):e202200391","journal-title":"J Biophotonics"},{"key":"11537_CR120","unstructured":"Loewen J, Post COVID (2023) Brain Fog Treatment: How to Think Clearly Again. https:\/\/www.cognitivefxusa.com\/blog\/post-covid-brain-fog-treatment, acessed on 17\/04\/2024"},{"key":"11537_CR121","doi-asserted-by":"publisher","first-page":"850583","DOI":"10.3389\/fphar.2022.850583","volume":"13","author":"C Spuch","year":"2022","unstructured":"Spuch C et al (2022) Efficacy and safety of lithium treatment in SARS-CoV-2 infected patients. Front Pharmacol 13:850583","journal-title":"Front Pharmacol"},{"key":"11537_CR122","doi-asserted-by":"crossref","unstructured":"O\u2019Kelly B et al (2022) Safety and efficacy of low dose Naltrexone in a long Covid cohort; an interventional pre-post study, vol 24. Brain, Behavior, & Immunity-Health, p 100485","DOI":"10.1016\/j.bbih.2022.100485"},{"issue":"14","key":"11537_CR123","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1055\/s-0028-1088314","volume":"74","author":"G Seelinger","year":"2008","unstructured":"Seelinger G, Merfort I, Schempp CM (2008) Anti-oxidant, anti-inflammatory and anti-allergic activities of Luteolin. Planta Med 74(14):1667\u20131677","journal-title":"Planta Med"},{"issue":"2","key":"11537_CR124","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/biof.1726","volume":"47","author":"TC Theoharides","year":"2021","unstructured":"Theoharides TC et al (2021) Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. BioFactors 47(2):232\u2013241","journal-title":"BioFactors"},{"key":"11537_CR125","doi-asserted-by":"publisher","unstructured":"Whitaker-Hardin B et al (2025) A narrative review of the efficacy of long COVID interventions on brain Fog, processing Speed, and other related cognitive outcomes. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13020421","DOI":"10.3390\/biomedicines13020421"},{"key":"11537_CR126","doi-asserted-by":"publisher","unstructured":"Uswatte G et al (2025) Long COVID brain fog treatment: an early-phase randomized controlled trial of constraint-induced cognitive therapy signals go. Rehabil Psychol. 10.1037\/rep0000626 https:\/\/doi.org\/10.1037\/rep0000626","DOI":"10.1037\/rep0000626"},{"key":"11537_CR127","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jpsychires.2022.10.045","volume":"156","author":"JB Zawilska","year":"2022","unstructured":"Zawilska JB, Kuczynska K (2022) Psychiatric and neurological complications of long COVID. J Psychiatr Res 156:349\u2013360","journal-title":"J Psychiatr Res"},{"issue":"3","key":"11537_CR128","doi-asserted-by":"publisher","first-page":"112189","DOI":"10.1016\/j.celrep.2023.112189","volume":"42","author":"FL Fontes-Dantas","year":"2023","unstructured":"Fontes-Dantas FL et al (2023) SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep 42(3):112189","journal-title":"Cell Rep"},{"issue":"21","key":"11537_CR129","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","volume":"110","author":"M Monje","year":"2022","unstructured":"Monje M, Iwasaki A (2022) The neurobiology of long COVID. Neuron 110(21):3484\u20133496","journal-title":"Neuron"},{"key":"11537_CR130","doi-asserted-by":"publisher","unstructured":"Leng A et al (2023) Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells. https:\/\/doi.org\/10.3390\/cells12050816","DOI":"10.3390\/cells12050816"},{"key":"11537_CR131","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbi.2021.12.007","volume":"100","author":"MG Frank","year":"2022","unstructured":"Frank MG et al (2022) SARS-CoV-2 Spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: evidence of PAMP-like properties. Brain Behav Immun 100:267\u2013277","journal-title":"Brain Behav Immun"},{"issue":"8","key":"11537_CR132","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1007\/s00415-022-11141-8","volume":"269","author":"M Calabria","year":"2022","unstructured":"Calabria M et al (2022) Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. J Neurol 269(8):3990\u20133999","journal-title":"J Neurol"},{"issue":"3","key":"11537_CR133","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","volume":"15","author":"AV Raveendran","year":"2021","unstructured":"Raveendran AV, Jayadevan R, Sashidharan S, Long COVID (2021) An overview. Diabetes Metab Syndr 15(3):869\u2013875","journal-title":"Diabetes Metab Syndr"},{"key":"11537_CR134","doi-asserted-by":"crossref","unstructured":"Gupta A et al (2024) A pilot study to assess blood-brain barrier permeability in long COVID. Brain Imaging Behav","DOI":"10.1007\/s11682-024-00877-8"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11537-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11537-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11537-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:06:09Z","timestamp":1771549569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11537-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11537"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11537-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"401"}}